EOSE enters its May 13 Q1 earnings call carrying the heaviest short positioning in the energy storage sector, an active securities fraud class action, and a stock that has shed 9% in a week despite a 25% bounce over the prior month.
Short sellers have built a formidable position in this name. Short interest hit 31.3% of the free float on May 5 — up from roughly 27.6% at the start of April, a 3.7 percentage point climb in five weeks. The rise was not a sudden spike; it has been a steady, deliberate build, with the most notable step-change arriving in the week of April 9-10, when SI jumped from about 27.5% to 29.3% in a single session. Days to cover from the latest FINRA settlement is 3.38, meaning any material short-covering would take more than three trading days at recent volumes to unwind. That is a structurally crowded position ahead of a binary catalyst.
The borrow market tells a different story about urgency. Cost to borrow has eased — it's now at 0.75%, down nearly 9% week-on-week and off the recent highs above 1% seen in late April. Availability has also loosened: the lending pool's availability sits at roughly 41% of short interest based on utilization data, compared to a 52-week peak where utilization hit 100% (full draw). At present utilization around 71%, there remains room to borrow, and cost pressures are not escalating. This is a heavily shorted stock where the borrow market is not yet in crisis — shorts can still add without paying a premium. Options lean call-heavy, with a PCR of 0.34, just below its 20-day average of 0.36, and running near the lower end of its year range (52-week low: 0.19). There is no unusual put-buying pressure ahead of earnings — options traders are not rushing to hedge.
The analyst community has spent the past two months moving progressively to the sidelines. JP Morgan's Mark Strouse cut his target from $9 to $6 in mid-April while holding a Neutral rating — a meaningful reset that now sits close to the current $6.23 price. The mean analyst price target across the Street is $8.86, which implies roughly 42% upside on paper, but that average is being dragged up by stale targets set before the February earnings collapse. Guggenheim downgraded to Neutral in late February, and Roth Capital halved its target from $12 to $6 the same week. The direction of travel is clear: analysts are not capitulating into a sell, but no one is defending a Buy either. The factor scorecard reinforces the tension — EPS surprise ranks in the 96th percentile and 90-day EPS momentum is in the top percentile of the universe, yet the short score ranks in just the 2nd percentile, meaning EOSE is among the most shorted stocks in the database.
The securities fraud backdrop adds a distinct layer of risk to the earnings setup. Multiple law firms ran class action lead-plaintiff deadlines on May 5, citing investor losses, and at least one action remains active. The suits appear to relate to the period around the catastrophic February earnings report, when the stock fell nearly 49% in a single day and 40% over the following five sessions. That print stands as the clearest recent data point on how violently this stock can move on an earnings miss — the subsequent March release produced a 14% gain, suggesting the reaction function is asymmetric and highly sensitive to guidance.
Institutional flows offer a sliver of support. BlackRock added 5 million shares in the most recent quarter, bringing its stake to 6.9% of shares outstanding. Vanguard added 3.1 million shares. More notably, the active manager Driehaus Capital nearly doubled its position to 4.2% of shares. On the insider side, CEO Joe Mastrangelo bought 83,900 shares across two transactions in early March at prices between $5.75 and $6.58, spending roughly $500,000. A director and an independent board member also bought in the same window. That cluster of insider buying — at prices near today's level — at minimum signals that management did not anticipate further structural deterioration when they put their own money in.
The next concrete reference point is the May 13 earnings call. The binary question for the market is whether EOSE can demonstrate progress toward gross margin positivity — the target the company itself set for Q1 2026. Given the February disaster and the litigation noise, even a neutral print may not be enough to move short sellers. What to watch is not just the headline number but whether guidance language changes enough to give the active buyers — Driehaus, the CEO, and the options call-buyers — any reason to hold.
See the live data behind this article on ORTEX.
Open EOSE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
